Preclinical characterization of amubarvimab and romlusevimab, a pair of non-competing neutralizing monoclonal antibody cocktail, against SARS-CoV-2.
对两种非竞争性中和单克隆抗体混合物 amubarvimab 和 romlusevimab 进行针对 SARS-CoV-2 的临床前表征
期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2022.980435
Ji Yun, Zhang Qi, Cheng Lin, Ge Jiwan, Wang Ruoke, Fang Mengqi, Mucker Eric M, Chen Peng, Ma Ji, Zhang Rui, Li Chunming, Hammond Holly, Baracco Lauren, Holbrook Michael, Frieman Matthew, Zhang Zheng, Wang Xinquan, Hooper Jay W, Zhang Linqi, Zhu Qing